Glycosidase inhibitors are important compounds that can interfere with several 
Introduction
Glycosydase inhibitors are a rapidly growing family of molecules mostly consisting of polyhydroxylated mono-and bicyclic saturated nitrogen heterocycles commonly referred to as iminosugars ( Figure 1 ). [1] [2] [3] Compounds like nojirimycin 1, 1-deoxynojirimycin 2, DMDP 3, castanospermine 4 or swainsonine 5 and their derivatives play crucial roles in the biological activities of some pharmaceutically important compounds. [4] [5] [6] 
Figure 1. Glycosidase inhibitors
Nojirimycin 1 was originally isolated from cultures of several strands of Streptomyces [7, 8] and Bacillus [9] and 1-deoxynojirimycin was isolated from plants of genus Morus. [10] Compounds 1 and 2 inhibit various glycosidases having important effects on the biosynthesis of membrane and secretory glycoproteins. [11] DMDP 3 can be isolated from the cyanobacterial genus Cylindrospermum and it is capable of effectively inhibiting digestive glycosidases. [12] The 6-deoxyderivative 4 has been isolated from Angylocalyx pynaertii and in contrast to other polyhydroxylated pyrrolidines it was found to be unique in inhibiting β-mannosidase. [13] Castanospermine 5 was first isolated from the seeds of Castanosperma australe [14] and it has demonstrated antiviral activity. [15, 16] It is also known that castanospermine interfere with the metabolism of glycogen [17] and it inhibits several glycosidases. [18] Swainsonine 6 was first isolated from swainsona in Australia but it is also present in numerous plants and fungi. Compound 6 has antitumoral activity [19, 20] although some clinical trials were discouraging. [21] Other natural pyrrolidine alkaloids like alexine 7, australine 8 and casuarine 9 have also been isolated from plants and microorganisms. [22] Post-print de Current Chemical Biology 2014, 8, [10] [11] [12] [13] [14] [15] [16] Calystegines were found in the medicinal plant Atropa belladonna and consist of a nortropane skeleton with three or four hydroxyl groups (Figure 2 ). There are up to 14 different structures of natural occurring calystegines isolated from a variety of vascular plants. They cannot be found in fungi or microorganisms. The chemistry and biology of calystegines including chemotaxonomy, biological activity and some insights on the biogenesis in the context of co-occurrence with tropane alkaloids have been compiled by Dräger in an excellent review [23] and a chapter book, [24] covering literature from 1998 to middle 2003 and up to 2007, respectively. Since then there has not been relevant communications in the topic; so, in this review calystegines will not be treated and for previous work the reader is directed to the above mentioned reviews.
Figure 2. Calystegines
The interest in glycosidase inhibitors has increased enormously during the past two decades and the number of synthetic approaches to their preparation is extremely extensive and growing at a rapid rate. [25, 26] One reason for this huge synthetic activity is the great variety of biological activity against different enzymes that can be found depending on the absolute configuration of the stereogenic centers bearing the hydroxyl groups.
The mechanism of the various existing glycosidases is known to proceed through oxocarbenium-like transition structures [27, 28] and it is well-accepted that inhibition of typical glycosidase inhibitors occur because such sugar mimics resemble the structural features of the transition state. [29] Different configurations as well as conformational restrictions in inhibitors help to a better recognition by the enzyme contributing to a higher inhibition activity. [30] In the large group of glycosidase inhibitors, synthetic studies have already been highlighted in several classes, [31] [32] [33] e.g. for pyrrolidines, [34, 35] piperidines, [36, 37] bicyclic compounds such as indolizidines [38] and pyrrolizidines [39, 40] and imino disaccharides. [41, 42] However, only a little is known about biosynthetic routes towards that sort of compounds. It can be expected that the knowledge of the biosynthetic pathways can be used to manipulate the metabolite pattern of involved microorganisms, directing the fermentation process to produce desired metabolites.
In this review, we summarize the current knowledge regarding the biosynthesis of naturally occurring glycosidase inhibitors. Semisynthetic studies on the structural and pharmaceutical properties of these compounds have been extensively reported and will not be covered here. Similarly, for detailed information of natural occurrence of discussed molecules and precise synthetic approaches the reader is referred to previous reviews. On the other hand, experimental evidences supporting the existence of various routes in microorganisms will be discussed.
Biosynthesis of monocyclic compounds. Piperidines and pyrrolidines
Nojririmycin 1 has been isolated from a variety of microorganisms including S.
roseochromogenes, S. lavendulae, S. nojiriensis and S. subrutilus. The last one, when grown on a glucose-containing soyabean medium produces both 1-deoxymannojirimycin and 1-deoxynojirimycin. Experiments with deuterated glucose showed incorporation of deuterium at C-6 in both alkaloids indicating that the first step in the biosynthesis of both iminosugars is the isomerization of glucose to fructose. Accordingly, it is proposed mannojirimycin 17 as the first iminosugar to be formed. [43] In fact, when 6,6- the biosynthesis have also been identified. Noteworthy, the same gene cluster has been found in Bacillus atrophaeus [48] as well as in Bacillus subtilis, [49] known producers of 1-deoxynojirimycin 1.
The biosynthetic route to 1-deoxynojirimycin 2 is, however, different for higher plants as demonstrated by Shibano and co-workers. [50] These authors studied the biosynthesis of 2 by using 1-[ 13 C]-glucose in the higher plant Commelia communis. While a significant 13 C enrichment was observed at C-6 for compound 2 obtained in microorganisms, in the case of that being produced in plants the 13 C enrichment was located at C-1. These experiments resulted in the proposal outlined in Scheme 2.
According to this hypothesis C-1/C-5 cyclization is produced in the original glucose molecule without any type of inversion. Additional support was provided by the fact that the same 13 C enrichment was observed in fructose obtained from administration of
Scheme 2. Biosynthesis of nojirimycin 1 and1-deoxynojirimycin 2 from D-glucose in

Commelia communis.
When imination is produced on fructose, formed by isomerization of glucose, the same process led to DMDP 3 (Scheme 3). Indeed, compound 3 is obtained from 1- Broussonetines are polyhydroxylated pyrrolidines bearing a long carbon chain at C-2.
They have been isolated from Broussonetia kazinoki. [51] 13 C NMR spectroscopy studies after feeding experiments using 1- enzymes involved in some steps. This topic has been reviewed elsewhere [57] and the reader is referred to that publication for more details concerning the biosynthesis of pipecolic acid.
The biosynthesis of slaframine 42 has been studied in Rhizoctonia leguminicola a fungus that causes black spot disease of red clover. [58] By using radiolabelled 1- The biosynthesis of swainsonine 6 has also been studied in plants. In particular, studies carried out with Astragalux oxyphysus showed that swainsonine 6 is biosynthesized in that plant by a very similar pathway (if not identical) to that in the fungus by incorporating pipecolic acid into the swainsonine skeleton. [66] On the other hand, it has been observed that the plant does not produce slaframine 42; neither does it produce intermediates 40 and 41.
The role of both pipecolic acid and malonic acid in the biosynthesis of swainsonine 6 has also been pointed out by stimulating production of such alkaloid by transformed root cultures of Swainsona galegifolia. [67] 
Conclusions
Polyhydroxylated saturated nitrogen heterocyles provided a variety of biosynthetic challenges. Up to now, several aspects related to their biogenesis have been revealed.
However, there is still much work to do. Further investigations are still required to clarify the biosynthetic enzymes involved in the catalytic processes. Such enzymes 
